Pathstone Family Office, LLC Athira Pharma, Inc. Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 425,492 shares of ATHA stock, worth $1.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

425,492

Previous 425,492 -0.0%

Holding current value

$1.96 Million

Previous $1.26 Million 31.55%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.26 - $4.22 $3.14 Million - $5.87 Million	-1,390,048 Reduced 76.56%	425,492 $1.06 Million
Q3 2022 Oct 23, 2023	BUY	$2.93 - $3.96 $371,231 - $501,732	126,700 Added 7.5%	1,815,540 $5.66 Million
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $371,231 - $501,732	126,700 Added 7.5%	1,815,540 $5.39 Million
Q2 2022 Oct 23, 2023	BUY	$2.74 - $13.43 $3.46 Million - $17 Million	1,263,348 Added 296.91%	1,688,840 $5.15 Million
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $162,482 - $796,399	59,300 Added 3.64%	1,688,840 $5.15 Million

Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $1.68 Million - $2.53 Million	187,293 Added 12.99%	1,629,540 $22 Million
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $2.71 Million - $4.85 Million	295,800 Added 25.8%	1,442,247 $18.8 Million
Q3 2021 Nov 16, 2021	BUY	$9.15 - $11.09 $4.44 Million - $5.38 Million	484,835 Added 73.28%	1,146,447 $10.8 Million
Q2 2021 Aug 31, 2021	BUY	$10.24 - $20.87 $1.66 Million - $3.39 Million	162,196 Added 32.48%	661,612 $6.78 Million
Q1 2021 May 14, 2021	BUY	$16.9 - $29.77 $7.06 Million - $12.4 Million	417,533 Added 509.91%	499,416 $9.19 Million
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $46,407 - $96,588	-2,816 Reduced 3.32%	81,883 $2.8 Million
Q3 2020 Nov 12, 2020	BUY	$16.02 - $18.46 $1.36 Million - $1.56 Million	84,699 New	84,699 $1.56 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

1.34M

Call Options Held

Put Options Held

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $174M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Athira Pharma, Inc. Transaction History